查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1867533

生物可吸收支架：全球市场占有率和排名、总收入和需求预测（2025-2031年）

Bioresorbable Scaffolds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 104 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球生物可吸收支架市场规模估计为 7.52 亿美元，预计到 2031 年将达到 18.81 亿美元，在 2025-2031 年预测期内的复合年增长率为 14.5%。

本报告对近期与生物可吸收支架相关的关税调整和国际战略反制措施进行了全面评估，评估内容包括跨境产业布局、资本配置模式、区域经济相互依存关係以及供应链重组。

生物可吸收支架是一种先进的介入治疗器械，可透过微创手术治疗血管狭窄。与永久留在体内的传统金属支架不同，生物可吸收支架由聚左旋乳酸（PLLA）、镁合金和锌合金等可生物降解材料製成。植入后，它们在癒合阶段提供机械支撑，然后逐渐降解并最终被人体完全吸收。这一过程减少了晚期血管再阻塞和血栓症等长期併发症，体现了「支撑-降解-修復」的综合治疗概念。生物可吸收支架融合了材料科学、组织工程和精准医学，代表着血管修復领域向临时性、生理性修復的变革性转变，尤其对年轻患者和对永久性植入耐受性有限的患者俱有重要价值。它们正成为下一代介入治疗的策略重点。预计到 2024 年，全球生物可吸收支架产量将达到约 378,000 个单位，全球平均市场价格约为每单位 2,000 美元。

生物可吸收支架市场正进入一个多元化成长的新阶段。同时，全球介入性心臟病学正朝着「生理修復」的概念转型，加速从永久性金属植入转向生物可降解支架解决方案的转变。大型医疗设备製造商正积极推动镁基和聚乳酸（PLLA）基支架平台的商业化，多个国家的监管机构也已针对这些创新产品实施了加速核准流程。此外，国家医保改革、集中采购机制以及三级医疗中心日益增长的兴趣，正为生物可吸收支架在包括冠状动脉疾病、外周血管疾病和儿科疾病在内的广泛适应症中的大规模应用奠定基础。随着适应症的不断扩大、本土企业的崛起以及医生教育的不断深入，该领域的商业性潜力正迅速释放。

儘管生物可吸收支架具有巨大的临床应用潜力，但该产业仍面临许多结构性挑战。早期产品在长期疗效方面有许多局限性，例如机械耐久性差、降解行为难以预测，令人担忧其疗效的持续性。此外，该产品的研发过程漫长且资金密集，上市前还需要大量的临床检验。许多地区的医保报销政策尚未完善或根本没有，导致医院和医生对采用该技术犹豫不决。所有这些因素共同为企业的现金流量和市场推广策略带来了挑战。

非永久性植入正日益受到临床关注，尤其是在年轻、高风险患者和慢性疾病患者中。这些患者群体更倾向于选择长期併发症较少且无需植入残留的治疗方法。随着介入手术的应用范围扩展到结构性心臟疾病、神经血管疾病和周围血管重组等领域，更多专业化和研究型医院致力于儘早开展临床应用。在中国，多家大型医院正与製造商合作进行真实世界研究（RWS），旨在增强医生信心，并推动医疗系统从试点应用过渡到标准采购。

本报告旨在按地区/国家、类型和应用对全球生物可吸收支架市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

本报告以2024年为基准年，按销量（千件）和收入（百万美元）对生物可吸收支架市场规模、估算和预测进行了呈现，并涵盖了2020年至2031年的历史数据和预测数据。定量和定性分析将帮助读者制定生物可吸收支架的业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Abbott
  • Boston Scientific
  • Wego Healthcare
  • Elixir
  • Arterial Remodeling Technologies
  • Lepu Medical
  • Huaan Bio
  • ELLA-CS

按类型分類的细分市场

  • 外周生物可吸收支架
  • 生物可吸收冠状动脉支架

应用领域

  • 医院和诊所
  • 心臟导管实验室
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Bioresorbable Scaffolds was estimated to be worth US$ 752 million in 2024 and is forecast to a readjusted size of US$ 1881 million by 2031 with a CAGR of 14.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Bioresorbable Scaffolds cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Bioresorbable Scaffolds are an advanced category of interventional devices designed for the treatment of vascular stenosis through minimally invasive procedures. Unlike conventional metallic stents that remain permanently in the body, these scaffolds are made from biodegradable materials such as poly-L-lactic acid (PLLA), magnesium alloys, or zinc alloys. Once implanted, they provide mechanical support during the healing phase and then gradually degrade, eventually being completely absorbed by the body. This process reduces long-term complications like late restenosis or thrombosis and embodies a comprehensive "support-degradation-repair" therapeutic paradigm. Combining material science, tissue engineering, and precision medicine, bioresorbable scaffolds represent a transformative shift toward temporary, physiology-driven vascular restoration-especially valuable for younger patients and those with limited tolerance to permanent implants. They are emerging as a strategic focus in next-generation interventional therapies.In 2024, global Bioresorbable Scaffolds production reached approximately 378 k units, with an average global market price of around US$ 2000 per unit

The bioresorbable scaffold market is entering a new phase of multidimensional growth. On one front, global interventional cardiology is shifting toward the concept of "physiological restoration," accelerating the transition from permanent metallic implants to biodegradable scaffolding solutions. Leading device manufacturers are driving commercialization of magnesium and PLLA-based platforms, while regulatory bodies in several countries have introduced fast-track approval pathways for such innovations. Simultaneously, national reimbursement reforms, centralized procurement mechanisms, and rising enthusiasm from tertiary hospitals are creating fertile ground for large-scale adoption across coronary, peripheral, and pediatric indications. As indications expand, local players emerge, and physician education deepens, the commercial potential of this segment is rapidly unlocking.

Despite its clinical promise, the bioresorbable scaffold industry faces structural hurdles. Early-generation products revealed limitations in long-term outcomes, such as insufficient mechanical durability and unpredictable degradation behavior, raising concerns about sustained efficacy. The development process is lengthy and capital-intensive, with extensive clinical validation required for market entry. Reimbursement policies remain fragmented or absent in many regions, increasing hesitancy among hospitals and physicians. Together, these factors pose dual challenges to enterprise cash flows and market cultivation strategies.

There is growing clinical interest in non-permanent implants, especially among younger high-risk patients and those with chronic conditions, who prefer therapies with fewer long-term complications and no residual implant. As interventional treatment expands into structural heart disease, neurovascular therapy, and peripheral vascular reconstruction, more specialty and research-oriented hospitals are engaging in early clinical use. In China, several leading hospitals are collaborating with manufacturers on real-world studies (RWS), which is expected to boost physician confidence and facilitate a transition from pilot usage to standardized procurement across the healthcare system.

This report aims to provide a comprehensive presentation of the global market for Bioresorbable Scaffolds, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bioresorbable Scaffolds by region & country, by Type, and by Application.

The Bioresorbable Scaffolds market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioresorbable Scaffolds.

Market Segmentation

By Company

  • Abbott
  • Boston Scientific
  • Wego Healthcare
  • Elixir
  • Arterial Remodeling Technologies
  • Lepu Medical
  • Huaan Bio
  • ELLA-CS

Segment by Type

  • Peripheral Bioabsorbable Stents
  • Coronary Bioabsorbable Stents

Segment by Application

  • Hospitals and Clinics
  • Cardiac Catheterization Laboratory
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Bioresorbable Scaffolds manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Bioresorbable Scaffolds in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Bioresorbable Scaffolds in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Bioresorbable Scaffolds Product Introduction
  • 1.2 Global Bioresorbable Scaffolds Market Size Forecast
    • 1.2.1 Global Bioresorbable Scaffolds Sales Value (2020-2031)
    • 1.2.2 Global Bioresorbable Scaffolds Sales Volume (2020-2031)
    • 1.2.3 Global Bioresorbable Scaffolds Sales Price (2020-2031)
  • 1.3 Bioresorbable Scaffolds Market Trends & Drivers
    • 1.3.1 Bioresorbable Scaffolds Industry Trends
    • 1.3.2 Bioresorbable Scaffolds Market Drivers & Opportunity
    • 1.3.3 Bioresorbable Scaffolds Market Challenges
    • 1.3.4 Bioresorbable Scaffolds Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Bioresorbable Scaffolds Players Revenue Ranking (2024)
  • 2.2 Global Bioresorbable Scaffolds Revenue by Company (2020-2025)
  • 2.3 Global Bioresorbable Scaffolds Players Sales Volume Ranking (2024)
  • 2.4 Global Bioresorbable Scaffolds Sales Volume by Company Players (2020-2025)
  • 2.5 Global Bioresorbable Scaffolds Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Bioresorbable Scaffolds Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Bioresorbable Scaffolds Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Bioresorbable Scaffolds
  • 2.9 Bioresorbable Scaffolds Market Competitive Analysis
    • 2.9.1 Bioresorbable Scaffolds Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Bioresorbable Scaffolds Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioresorbable Scaffolds as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Peripheral Bioabsorbable Stents
    • 3.1.2 Coronary Bioabsorbable Stents
  • 3.2 Global Bioresorbable Scaffolds Sales Value by Type
    • 3.2.1 Global Bioresorbable Scaffolds Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Bioresorbable Scaffolds Sales Value, by Type (2020-2031)
    • 3.2.3 Global Bioresorbable Scaffolds Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Bioresorbable Scaffolds Sales Volume by Type
    • 3.3.1 Global Bioresorbable Scaffolds Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Bioresorbable Scaffolds Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Bioresorbable Scaffolds Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Bioresorbable Scaffolds Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospitals and Clinics
    • 4.1.2 Cardiac Catheterization Laboratory
    • 4.1.3 Other
  • 4.2 Global Bioresorbable Scaffolds Sales Value by Application
    • 4.2.1 Global Bioresorbable Scaffolds Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Bioresorbable Scaffolds Sales Value, by Application (2020-2031)
    • 4.2.3 Global Bioresorbable Scaffolds Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Bioresorbable Scaffolds Sales Volume by Application
    • 4.3.1 Global Bioresorbable Scaffolds Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Bioresorbable Scaffolds Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Bioresorbable Scaffolds Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Bioresorbable Scaffolds Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Bioresorbable Scaffolds Sales Value by Region
    • 5.1.1 Global Bioresorbable Scaffolds Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Bioresorbable Scaffolds Sales Value by Region (2020-2025)
    • 5.1.3 Global Bioresorbable Scaffolds Sales Value by Region (2026-2031)
    • 5.1.4 Global Bioresorbable Scaffolds Sales Value by Region (%), (2020-2031)
  • 5.2 Global Bioresorbable Scaffolds Sales Volume by Region
    • 5.2.1 Global Bioresorbable Scaffolds Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Bioresorbable Scaffolds Sales Volume by Region (2020-2025)
    • 5.2.3 Global Bioresorbable Scaffolds Sales Volume by Region (2026-2031)
    • 5.2.4 Global Bioresorbable Scaffolds Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Bioresorbable Scaffolds Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Bioresorbable Scaffolds Sales Value, 2020-2031
    • 5.4.2 North America Bioresorbable Scaffolds Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Bioresorbable Scaffolds Sales Value, 2020-2031
    • 5.5.2 Europe Bioresorbable Scaffolds Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Bioresorbable Scaffolds Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Bioresorbable Scaffolds Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Bioresorbable Scaffolds Sales Value, 2020-2031
    • 5.7.2 South America Bioresorbable Scaffolds Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Bioresorbable Scaffolds Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Bioresorbable Scaffolds Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Bioresorbable Scaffolds Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Bioresorbable Scaffolds Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Bioresorbable Scaffolds Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Bioresorbable Scaffolds Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Bioresorbable Scaffolds Sales Value, 2020-2031
    • 6.3.2 United States Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Bioresorbable Scaffolds Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Bioresorbable Scaffolds Sales Value, 2020-2031
    • 6.4.2 Europe Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Bioresorbable Scaffolds Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Bioresorbable Scaffolds Sales Value, 2020-2031
    • 6.5.2 China Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Bioresorbable Scaffolds Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Bioresorbable Scaffolds Sales Value, 2020-2031
    • 6.6.2 Japan Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Bioresorbable Scaffolds Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Bioresorbable Scaffolds Sales Value, 2020-2031
    • 6.7.2 South Korea Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Bioresorbable Scaffolds Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Bioresorbable Scaffolds Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Bioresorbable Scaffolds Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Bioresorbable Scaffolds Sales Value, 2020-2031
    • 6.9.2 India Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Bioresorbable Scaffolds Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Abbott
    • 7.1.1 Abbott Company Information
    • 7.1.2 Abbott Introduction and Business Overview
    • 7.1.3 Abbott Bioresorbable Scaffolds Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Abbott Bioresorbable Scaffolds Product Offerings
    • 7.1.5 Abbott Recent Development
  • 7.2 Boston Scientific
    • 7.2.1 Boston Scientific Company Information
    • 7.2.2 Boston Scientific Introduction and Business Overview
    • 7.2.3 Boston Scientific Bioresorbable Scaffolds Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Boston Scientific Bioresorbable Scaffolds Product Offerings
    • 7.2.5 Boston Scientific Recent Development
  • 7.3 Wego Healthcare
    • 7.3.1 Wego Healthcare Company Information
    • 7.3.2 Wego Healthcare Introduction and Business Overview
    • 7.3.3 Wego Healthcare Bioresorbable Scaffolds Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Wego Healthcare Bioresorbable Scaffolds Product Offerings
    • 7.3.5 Wego Healthcare Recent Development
  • 7.4 Elixir
    • 7.4.1 Elixir Company Information
    • 7.4.2 Elixir Introduction and Business Overview
    • 7.4.3 Elixir Bioresorbable Scaffolds Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Elixir Bioresorbable Scaffolds Product Offerings
    • 7.4.5 Elixir Recent Development
  • 7.5 Arterial Remodeling Technologies
    • 7.5.1 Arterial Remodeling Technologies Company Information
    • 7.5.2 Arterial Remodeling Technologies Introduction and Business Overview
    • 7.5.3 Arterial Remodeling Technologies Bioresorbable Scaffolds Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Arterial Remodeling Technologies Bioresorbable Scaffolds Product Offerings
    • 7.5.5 Arterial Remodeling Technologies Recent Development
  • 7.6 Lepu Medical
    • 7.6.1 Lepu Medical Company Information
    • 7.6.2 Lepu Medical Introduction and Business Overview
    • 7.6.3 Lepu Medical Bioresorbable Scaffolds Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Lepu Medical Bioresorbable Scaffolds Product Offerings
    • 7.6.5 Lepu Medical Recent Development
  • 7.7 Huaan Bio
    • 7.7.1 Huaan Bio Company Information
    • 7.7.2 Huaan Bio Introduction and Business Overview
    • 7.7.3 Huaan Bio Bioresorbable Scaffolds Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Huaan Bio Bioresorbable Scaffolds Product Offerings
    • 7.7.5 Huaan Bio Recent Development
  • 7.8 ELLA-CS
    • 7.8.1 ELLA-CS Company Information
    • 7.8.2 ELLA-CS Introduction and Business Overview
    • 7.8.3 ELLA-CS Bioresorbable Scaffolds Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 ELLA-CS Bioresorbable Scaffolds Product Offerings
    • 7.8.5 ELLA-CS Recent Development

8 Industry Chain Analysis

  • 8.1 Bioresorbable Scaffolds Industrial Chain
  • 8.2 Bioresorbable Scaffolds Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Bioresorbable Scaffolds Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Bioresorbable Scaffolds Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Bioresorbable Scaffolds Market Trends
  • Table 2. Bioresorbable Scaffolds Market Drivers & Opportunity
  • Table 3. Bioresorbable Scaffolds Market Challenges
  • Table 4. Bioresorbable Scaffolds Market Restraints
  • Table 5. Global Bioresorbable Scaffolds Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Bioresorbable Scaffolds Revenue Market Share by Company (2020-2025)
  • Table 7. Global Bioresorbable Scaffolds Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Bioresorbable Scaffolds Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Bioresorbable Scaffolds Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Bioresorbable Scaffolds Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Bioresorbable Scaffolds Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Bioresorbable Scaffolds
  • Table 13. Global Bioresorbable Scaffolds Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioresorbable Scaffolds as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Bioresorbable Scaffolds Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Bioresorbable Scaffolds Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Bioresorbable Scaffolds Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Bioresorbable Scaffolds Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Bioresorbable Scaffolds Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Bioresorbable Scaffolds Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Bioresorbable Scaffolds Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Bioresorbable Scaffolds Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Bioresorbable Scaffolds Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Bioresorbable Scaffolds Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Bioresorbable Scaffolds Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Bioresorbable Scaffolds Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Bioresorbable Scaffolds Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Bioresorbable Scaffolds Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Bioresorbable Scaffolds Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Bioresorbable Scaffolds Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Bioresorbable Scaffolds Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Bioresorbable Scaffolds Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Bioresorbable Scaffolds Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Bioresorbable Scaffolds Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Bioresorbable Scaffolds Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Bioresorbable Scaffolds Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Bioresorbable Scaffolds Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Bioresorbable Scaffolds Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Bioresorbable Scaffolds Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Bioresorbable Scaffolds Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Bioresorbable Scaffolds Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Bioresorbable Scaffolds Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Bioresorbable Scaffolds Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Bioresorbable Scaffolds Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Bioresorbable Scaffolds Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Bioresorbable Scaffolds Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Bioresorbable Scaffolds Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Bioresorbable Scaffolds Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Bioresorbable Scaffolds Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Bioresorbable Scaffolds Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Bioresorbable Scaffolds Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Bioresorbable Scaffolds Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Bioresorbable Scaffolds Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Bioresorbable Scaffolds Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Bioresorbable Scaffolds Sales Volume, (2026-2031) & (K Units)
  • Table 57. Abbott Company Information
  • Table 58. Abbott Introduction and Business Overview
  • Table 59. Abbott Bioresorbable Scaffolds Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Abbott Bioresorbable Scaffolds Product Offerings
  • Table 61. Abbott Recent Development
  • Table 62. Boston Scientific Company Information
  • Table 63. Boston Scientific Introduction and Business Overview
  • Table 64. Boston Scientific Bioresorbable Scaffolds Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Boston Scientific Bioresorbable Scaffolds Product Offerings
  • Table 66. Boston Scientific Recent Development
  • Table 67. Wego Healthcare Company Information
  • Table 68. Wego Healthcare Introduction and Business Overview
  • Table 69. Wego Healthcare Bioresorbable Scaffolds Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Wego Healthcare Bioresorbable Scaffolds Product Offerings
  • Table 71. Wego Healthcare Recent Development
  • Table 72. Elixir Company Information
  • Table 73. Elixir Introduction and Business Overview
  • Table 74. Elixir Bioresorbable Scaffolds Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Elixir Bioresorbable Scaffolds Product Offerings
  • Table 76. Elixir Recent Development
  • Table 77. Arterial Remodeling Technologies Company Information
  • Table 78. Arterial Remodeling Technologies Introduction and Business Overview
  • Table 79. Arterial Remodeling Technologies Bioresorbable Scaffolds Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Arterial Remodeling Technologies Bioresorbable Scaffolds Product Offerings
  • Table 81. Arterial Remodeling Technologies Recent Development
  • Table 82. Lepu Medical Company Information
  • Table 83. Lepu Medical Introduction and Business Overview
  • Table 84. Lepu Medical Bioresorbable Scaffolds Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Lepu Medical Bioresorbable Scaffolds Product Offerings
  • Table 86. Lepu Medical Recent Development
  • Table 87. Huaan Bio Company Information
  • Table 88. Huaan Bio Introduction and Business Overview
  • Table 89. Huaan Bio Bioresorbable Scaffolds Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Huaan Bio Bioresorbable Scaffolds Product Offerings
  • Table 91. Huaan Bio Recent Development
  • Table 92. ELLA-CS Company Information
  • Table 93. ELLA-CS Introduction and Business Overview
  • Table 94. ELLA-CS Bioresorbable Scaffolds Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. ELLA-CS Bioresorbable Scaffolds Product Offerings
  • Table 96. ELLA-CS Recent Development
  • Table 97. Key Raw Materials Lists
  • Table 98. Raw Materials Key Suppliers Lists
  • Table 99. Bioresorbable Scaffolds Downstream Customers
  • Table 100. Bioresorbable Scaffolds Distributors List
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Bioresorbable Scaffolds Product Picture
  • Figure 2. Global Bioresorbable Scaffolds Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Bioresorbable Scaffolds Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Bioresorbable Scaffolds Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Bioresorbable Scaffolds Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Bioresorbable Scaffolds Report Years Considered
  • Figure 7. Global Bioresorbable Scaffolds Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Bioresorbable Scaffolds Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bioresorbable Scaffolds Revenue in 2024
  • Figure 10. Bioresorbable Scaffolds Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Peripheral Bioabsorbable Stents Picture
  • Figure 12. Coronary Bioabsorbable Stents Picture
  • Figure 13. Global Bioresorbable Scaffolds Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Bioresorbable Scaffolds Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Bioresorbable Scaffolds Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 16. Global Bioresorbable Scaffolds Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Bioresorbable Scaffolds Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Hospitals and Clinics
  • Figure 19. Product Picture of Cardiac Catheterization Laboratory
  • Figure 20. Product Picture of Other
  • Figure 21. Global Bioresorbable Scaffolds Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Bioresorbable Scaffolds Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Bioresorbable Scaffolds Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 24. Global Bioresorbable Scaffolds Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Bioresorbable Scaffolds Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Bioresorbable Scaffolds Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Bioresorbable Scaffolds Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Bioresorbable Scaffolds Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Bioresorbable Scaffolds Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Bioresorbable Scaffolds Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Bioresorbable Scaffolds Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Bioresorbable Scaffolds Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Bioresorbable Scaffolds Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Bioresorbable Scaffolds Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Bioresorbable Scaffolds Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Bioresorbable Scaffolds Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Bioresorbable Scaffolds Sales Volume (%), (2020-2031)
  • Figure 38. United States Bioresorbable Scaffolds Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Bioresorbable Scaffolds Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Bioresorbable Scaffolds Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Bioresorbable Scaffolds Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Bioresorbable Scaffolds Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Bioresorbable Scaffolds Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Bioresorbable Scaffolds Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Bioresorbable Scaffolds Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Bioresorbable Scaffolds Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Bioresorbable Scaffolds Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Bioresorbable Scaffolds Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Bioresorbable Scaffolds Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Bioresorbable Scaffolds Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Bioresorbable Scaffolds Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Bioresorbable Scaffolds Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Bioresorbable Scaffolds Industrial Chain
  • Figure 60. Bioresorbable Scaffolds Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed